Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An aggressive malignant smooth muscle neoplasm, arising from the prostate. It is characterized by a proliferation of neoplastic spindle cells.
Biomarker and diagnostic research for prostate leiomyosarcoma has been reported in the published literature.
No clinical trials have been registered for prostate leiomyosarcoma.
27 publications have been identified in PubMed for prostate leiomyosarcoma. Research spans Case Report / Case Series (33%), Epidemiology / Natural History (22%), and Review / Meta-Analysis (19%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 9 | 33% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 6:42 AM UTC
6 |
22% |
Research summaries | 5 | 19% |
Clinical study results | 3 | 11% |
Other research | 1 | 4% |
Testing and diagnosis research | 1 | 4% |
Laboratory research | 1 | 4% |
New treatment approaches | 1 | 4% |
Tisekar S (2026). [PMID: 41510517](https://pubmed.ncbi.nlm.nih.gov/41510517/). *Proc (Bayl Univ Med Cent)*. [Diagnostic / Biomarker]
Lee EY (2026). [PMID: 41752671](https://pubmed.ncbi.nlm.nih.gov/41752671/). *Medicina (Kaunas)*. [Epidemiology / Natural History]
Tran TT (2026). [PMID: 41884856](https://pubmed.ncbi.nlm.nih.gov/41884856/). *Urol Case Rep*. [Case Report / Case Series]
Romanish M (2025). [PMID: 40638990](https://pubmed.ncbi.nlm.nih.gov/40638990/). *Ann Diagn Pathol*. [Other]
Bogani G (2025). [PMID: 40743869](https://pubmed.ncbi.nlm.nih.gov/40743869/). *Int J Gynecol Cancer*. [Review / Meta-Analysis]
Kleiburg F (2025). [PMID: 40146266](https://pubmed.ncbi.nlm.nih.gov/40146266/). *Eur J Nucl Med Mol Imaging*. [Clinical Trial Publication]
Ando Y (2025). [PMID: 40065871](https://pubmed.ncbi.nlm.nih.gov/40065871/). *Cureus*. [Case Report / Case Series]
Jiménez-Martínez LE (2025). [PMID: 40686510](https://pubmed.ncbi.nlm.nih.gov/40686510/). *Urol Case Rep*. [Case Report / Case Series]
Lamo-Espinosa JM (2025). [PMID: 40244368](https://pubmed.ncbi.nlm.nih.gov/40244368/). *Arch Orthop Trauma Surg*. [Review / Meta-Analysis]
Settaf-Cherif L (2025). [PMID: 41725966](https://pubmed.ncbi.nlm.nih.gov/41725966/). *Cent European J Urol*. [Review / Meta-Analysis]